Metronidazole

Metronidazole

SCHEMBL2221140

Cc1ncc([N+](=O)[O-])n1CCO.Cc1ncc([N+](=O)[O-])n1CCO

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 1.00
ALDH1A1 P00352 3/20 1.00
MAPK1 P28482 2/20 1.00
THRB P10828 1/20 1.00
TSHR P16473 1/20 1.00
CA1 P00915 5/20 0.64
CA2 P00918 5/20 0.64
CA9 Q16790 5/20 0.64
SMN1; SMN2 Q16637 1/20 0.64
GLA P06280 1/20 0.63
ATM Q13315 1/20 0.63
CA12 O43570 4/20 0.59
CHRM1 P11229 1/20 0.58
GAA P10253 1/20 0.56
KMT2A Q03164 2/20 0.54
MEN1 O00255 1/20 0.53
KDM4E B2RXH2 1/20 0.52
MAPT P10636 1/20 0.52
POLB P06746 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Metronidazole SCHEMBL9481347 1.00 LMNA (1.00) LMNAALDH1A1MAPK1THRBTSHR
Metronidazole SCHEMBL9455119 1.00 LMNA (1.00) LMNAALDH1A1MAPK1THRBTSHR
Metronidazole SCHEMBL23042 1.00 LMNA (1.00) LMNAALDH1A1MAPK1THRBTSHR
Metronidazole SCHEMBL31108924 1.00 LMNA (1.00) LMNAALDH1A1MAPK1THRBTSHR
Metronidazole SCHEMBL9482744 1.00 LMNA (1.00) LMNAALDH1A1MAPK1THRBTSHR
Metronidazole SCHEMBL5313560 1.00 LMNA (1.00) LMNAALDH1A1MAPK1THRBTSHR
Metronidazole SCHEMBL5595814 0.98 LMNA (0.97) LMNAALDH1A1MAPK1THRBTSHR
Metronidazole SCHEMBL8675069 0.98 LMNA (0.97) LMNAALDH1A1MAPK1THRBTSHR
Metronidazole SCHEMBL3453244 0.98 LMNA (0.97) LMNAALDH1A1MAPK1THRBTSHR
Metronidazole SCHEMBL21295019 0.98 LMNA (0.97) LMNAALDH1A1MAPK1THRBTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115350174-B Application of L-norvaline in preparing medicines for treating ventricular remodeling after myocardial infarction 上海大学 2024-04-26 CN disclosed
WO-2024073167-A1 DEEP EUTECTIC SOLVENT ADDITIVES DUNN-EDWARDS CORPORATION (US) 2024-04-04 WO disclosed
CN-115105528-B Application of Prussian blue coordinated cobalt nano-enzyme in promoting heart regeneration 天津大学 2023-12-01 CN disclosed
CN-110246526-B Memory device 爱思开海力士有限公司 2022-12-02 CN disclosed
CN-115292274-A Data warehouse topic model construction method and system 江苏昆山农村商业银行股份有限公司 2022-11-04 CN disclosed
CN-111737018-B ZooKeeper configuration file storage processing method, device, equipment and medium thereof 腾讯科技(深圳)有限公司 2020-12-22 CN disclosed
CN-111737018-A ZooKeeper configuration file storage processing method, device, equipment and medium thereof 腾讯科技(深圳)有限公司 2020-10-02 CN disclosed
EP-3697921-A1 CONTROLLING FUNGAL PATHOGENS USING RNAi-BASED STRATEGY The Regents of the University of California (US) 2020-08-26 EP disclosed
EP-3655104-A1 AN OSTEOADSORPTIVE FLUOROGENIC SUBSTRATE OF CATHEPSIN K FOR IMAGING OSTEOCLAST ACTIVITY AND MIGRATION The Regents of the University of California (US) 2020-05-27 EP disclosed
WO-2019079044-A1 CONTROLLING FUNGAL PATHOGENS USING RNAi-BASED STRATEGY THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2019-04-25 WO disclosed
US-5618559-A CONTACTING METRONIDAZOLE AND DILUENTS WITH AQUEOUS EXPANDABLE POLYMETHACRYLIC ACID ESTER COPOLYMER AND DETACKIFYING AGENT, COMPRESSING TO FORM TABLETS G.D. SEARLE & CO. (US) 1997-04-08 US disclosed
US-5529990-A ANTIBIOTICS; USEFUL TO TREAT INFECTIONS CAUSED BY BACTERIAL ORGANISM, INCLUDING THOSE WHICH ARE TETRACYCLINE-RESISTANCE AMERICAN CYANAMID COMPANY (US) 1996-06-25 US disclosed
US-5530117-A ANTIBIOTICS AMERICAN CYANAMID COMPANY (US) 1996-06-25 US disclosed
US-5494903-A 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines AMERICAN CYANAMID COMPANY (US) 1996-02-27 US disclosed
WO-1995028929-A1 AMINOLINE-N-OXIDE ANTIMICROBIALS FOR USE AGAINST H. PYLORI INFECTIONS RPMS TECHNOLOGY LIMITED (GB) 1995-11-02 WO disclosed
EP-0636368-A1 The use of 2- phenylmethylene -1- 3'-(amino)-2'-(hydroxy)--propoxy-imino -cyclohexane derivatives EGIS GYOGYSZERGYAR RT. (HU) 1995-02-01 EP disclosed
US-4938796-A Haloalkamides and naphthalene anhydride ICI AMERICAS INC. (US) 1990-07-03 US disclosed
US-4859694-A USING METRONIDAZOLE PAVLICH FREDERICK M (US) 1989-08-22 US disclosed
US-4709611-A Electronic musical instrument for generating a natural musical tone MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) 1987-12-01 US disclosed
US-4218982-A Pattern generating system for use in electronic sewing machines KOYO SEIKO COMPANY LIMITED (JP) 1980-08-26 US disclosed